OR WAIT null SECS
Novavax
W. Aaron Pruett is drug product process engineer, Novavax.
The objective of this study was to assess the impact of manufacturing-scale, freeze-thaw conditions on aggregation and subvisible particle formation of a monoclonal antibody solution (mAb-A; IgG1) using a small-scale model.